NINJA02 STAGING |

2010 JP Morgan Healthcare Conference Report

Who is Investing in Biotech Today? Kris Jenner
Reconsidering Small and Mid Caps, IPOs, and Value Drivers. Kris Jenner
Shareholder Activism in 2010, Good or Bad? Kris Jenner
2010 JP Morgan Healthcare Conference, the Insider Perspective
Key Issues for Venture Capital Invetments and Fund Raising. Ansbert Gadicke
Pharma Opportunities, Novel Technologies, and Diseases of the Decade. Ansbert Gadicke
The Insider Perspective, with Geoff Meacham (Part 1)
The Insider Perspective, with Geoff Meacham (Part 2)

Fred Frank and Dennis Purcell Comment on New Year

2009 in Review, the M&A and Venture Perspectives
2010, Where Do We Go From Here?
FAST Word Association Game, with Fred Frank and Dennis Purcell

An Official NASDAQ Perspective on Biotech, with Bob McCooey

Biotech Markets in 2009
Expectations for Biotech in 2010
Helping Smaller Biotech Companies Stay Listed

Stem Cell Review: Episode 10

Show: Biotech In The Money | Guest: Kris Jenner, T.Rowe Price
Channels: Finance | Date: January 12th, 2010

Bob Langer
Organogenesis

Stem Cell Review: Episode 9 (NEW 2/16/2010)

Stem Cell Review: AutoImmune Diseases & Blood Disorders (EP9) What are Hematopoietic Stem Cells (HSCs)? Where can we we find them? Where do they originate? Hanna Mikkola of UCLA helps us understand HSC, the current limitations in cell expansion that are limiting clinical use, as well as the direction of the efforts being made today ...